Dopamine receptor D4: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Dopamine Receptor D4 == | |||
[[File:D4_ligands.png|thumb|right|300px|Chemical structure of various D4 ligands.]] | |||
The '''dopamine receptor D4''' (DRD4) is a [[G protein-coupled receptor]] that is encoded by the DRD4 gene in humans. It is one of the five types of [[dopamine receptor]]s, which are responsible for the physiological effects of the neurotransmitter [[dopamine]]. The D4 receptor is of particular interest due to its role in the modulation of [[cognition]], [[emotion]], and [[behavior]]. | |||
== | == Structure == | ||
The D4 receptor is a member of the D2-like receptor family, which also includes the [[dopamine receptor D2]] and [[dopamine receptor D3]]. These receptors are characterized by their ability to inhibit the enzyme [[adenylyl cyclase]] through the activation of [[Gi/o proteins]]. The D4 receptor has a high degree of polymorphism, particularly in the third intracellular loop, which may influence its function and expression. | |||
== | == Function == | ||
D4 receptors are primarily found in the [[frontal cortex]], [[amygdala]], [[hypothalamus]], and [[hippocampus]]. They play a crucial role in modulating synaptic transmission and are involved in the regulation of [[mood]], [[attention]], and [[reward]]. The D4 receptor has been implicated in various [[neuropsychiatric disorders]], including [[schizophrenia]], [[bipolar disorder]], and [[attention deficit hyperactivity disorder]] (ADHD). | |||
== Ligands == | |||
[[File:D4_ligands.png|thumb|left|300px|Examples of D4 receptor ligands.]] | |||
D4 receptors can be targeted by various ligands, which can act as either agonists or antagonists. Agonists such as [[apomorphine]] and [[dopamine]] itself activate the receptor, while antagonists like [[clozapine]] and [[haloperidol]] inhibit its activity. The development of selective D4 receptor ligands is an area of active research, with potential therapeutic applications in treating [[psychiatric disorders]]. | |||
== Clinical Significance == | |||
The D4 receptor has been studied extensively in the context of [[pharmacogenetics]], as variations in the DRD4 gene have been associated with differences in drug response and susceptibility to certain disorders. For example, the 7-repeat allele of the DRD4 gene has been linked to an increased risk of ADHD and [[novelty seeking]] behavior. | |||
== Related Pages == | |||
* [[Dopamine receptor]] | |||
* [[G protein-coupled receptor]] | |||
* [[Neurotransmitter]] | |||
* [[Schizophrenia]] | |||
* [[Attention deficit hyperactivity disorder]] | |||
[[Category:Dopamine receptors]] | |||
[[Category:G protein-coupled receptors]] | [[Category:G protein-coupled receptors]] | ||
[[Category: | [[Category:Neurotransmitter receptors]] | ||
Latest revision as of 12:09, 15 February 2025
Dopamine Receptor D4[edit]

The dopamine receptor D4 (DRD4) is a G protein-coupled receptor that is encoded by the DRD4 gene in humans. It is one of the five types of dopamine receptors, which are responsible for the physiological effects of the neurotransmitter dopamine. The D4 receptor is of particular interest due to its role in the modulation of cognition, emotion, and behavior.
Structure[edit]
The D4 receptor is a member of the D2-like receptor family, which also includes the dopamine receptor D2 and dopamine receptor D3. These receptors are characterized by their ability to inhibit the enzyme adenylyl cyclase through the activation of Gi/o proteins. The D4 receptor has a high degree of polymorphism, particularly in the third intracellular loop, which may influence its function and expression.
Function[edit]
D4 receptors are primarily found in the frontal cortex, amygdala, hypothalamus, and hippocampus. They play a crucial role in modulating synaptic transmission and are involved in the regulation of mood, attention, and reward. The D4 receptor has been implicated in various neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD).
Ligands[edit]

D4 receptors can be targeted by various ligands, which can act as either agonists or antagonists. Agonists such as apomorphine and dopamine itself activate the receptor, while antagonists like clozapine and haloperidol inhibit its activity. The development of selective D4 receptor ligands is an area of active research, with potential therapeutic applications in treating psychiatric disorders.
Clinical Significance[edit]
The D4 receptor has been studied extensively in the context of pharmacogenetics, as variations in the DRD4 gene have been associated with differences in drug response and susceptibility to certain disorders. For example, the 7-repeat allele of the DRD4 gene has been linked to an increased risk of ADHD and novelty seeking behavior.